Works matching IS 0091150X AND DT 2022 AND VI 56 AND IP 1
Results: 19
Preparation and Mechanism of the Antitumor Action of a 4H-Aminochromene Compound.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 12, doi. 10.1007/s11094-022-02593-3
- By:
- Publication type:
- Article
Synthesis of 2-(1-Oxo-3-Carboxypropoxy)-Methyl-5,10,15,20-Tetraphenylporphin and Evaluation of Its Photodynamic Anti-Esophageal Cytotoxic Effect.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 48, doi. 10.1007/s11094-022-02602-5
- By:
- Publication type:
- Article
Physicochemical Properties and Methods of Analysis of Vildagliptin (Review).
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 110, doi. 10.1007/s11094-022-02606-1
- By:
- Publication type:
- Article
Synthesis and Antibacterial Activity of 1,2,3,4-Tetrahydro- and Pyrido[1,2-a]Benzimidazoles.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 22, doi. 10.1007/s11094-022-02596-0
- By:
- Publication type:
- Article
Biopharmaceutical, Toxicological, and Morphological Assessment of an Antiallergenic Medicine for External Application.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 16, doi. 10.1007/s11094-022-02595-1
- By:
- Publication type:
- Article
A Method for Assay of Losartan, Its Active Metabolite E-3174, and Glibenclamide in Human Serum and Urine by HPLC-MS/MS.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 118, doi. 10.1007/s11094-022-02612-3
- By:
- Publication type:
- Article
Development and Validation of Stability-Indicating UPLC Method for Simultaneous Determination of Glecaprevir and Pibrentasvir.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 138, doi. 10.1007/s11094-022-02611-4
- By:
- Publication type:
- Article
Development and Validation of a Stability-Indicating RP-HPLC Method for the Determination of Erythromycin Related Impurities in Topical Dosage Form.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 131, doi. 10.1007/s11094-022-02610-5
- By:
- Publication type:
- Article
Development of a Method for Assay of Flavonoids and Chlorhexidine in Medicinal Wound-Healing Pencil Formulations.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 126, doi. 10.1007/s11094-022-02609-y
- By:
- Publication type:
- Article
A Potential Method for Standardization of Multiphytoadaptogen: Tandem Mass Spectrometry for Analysis of Biologically Active Substances from Rhodiola rosea.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 78, doi. 10.1007/s11094-022-02607-0
- By:
- Publication type:
- Article
Potential Directions in the Use of Graphene Nanomaterials in Pharmacology and Biomedicine (Review).
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 1, doi. 10.1007/s11094-022-02594-2
- By:
- Publication type:
- Article
Chemical Composition and Cytotoxic Activity of Lindera pulcherrima VAR. Hemsleyana.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 101, doi. 10.1007/s11094-022-02605-2
- By:
- Publication type:
- Article
Optimization of Phenolics Extraction from Strobilanthes cusia Leaves and Their Antioxidant Activity.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 94, doi. 10.1007/s11094-022-02604-3
- By:
- Publication type:
- Article
Investigation of the Apoptotic and Membrane Effects of Essential Oils Obtained from Wild and Cultured Forms of Origanum acutidens (Hand.-Mazz.) Ietswaart on Epidermoid Cancer (A-431) Cells.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 85, doi. 10.1007/s11094-022-02603-4
- By:
- Publication type:
- Article
Allyl Functionalized Benzimidazolium-Derived Ag(I)-N-Heterocyclic Carbene Complexes: Anti-Biofilm and Antimicrobial Properties.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 54, doi. 10.1007/s11094-022-02601-6
- By:
- Publication type:
- Article
Synthesis and Evaluation of Monoaryl Derivatives as Transthyretin Fibril Formation Inhibitors.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 38, doi. 10.1007/s11094-022-02600-7
- By:
- Publication type:
- Article
Cyclin-Dependent Kinase 4 and 6 Inhibitors as Breast Cancer Therapy: Research Progress and Prospects.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 71, doi. 10.1007/s11094-022-02599-x
- By:
- Publication type:
- Article
Synthesis of Some New N-Alkyl/Aralkyl-N-(2,3-Dihydro-1,4-Benzodioxin-6-YL)-4-Bromobenzenesulfonamides as Possible Therapeutic Agents F or Alzheimer's Disease.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 61, doi. 10.1007/s11094-022-02598-y
- By:
- Publication type:
- Article
Piperazine Heterocycles as Potential Anticancer Agents: A Review.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 56, n. 1, p. 29, doi. 10.1007/s11094-022-02597-z
- By:
- Publication type:
- Article